Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

NCT05650476 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

DRUG: Talazoparib

Sponsor

Pfizer